「ag」の検索結果
47件：1～5件目を表示
-
お知らせ | 千寿製薬株式会社
a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”...
https://www.senju.co.jp/chinese/news/ -
therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. P...
https://www.senju.co.jp/rd/thesis/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
emy of Ophthalmology (APAO) Congress 開催日：2026年2月5日～2026年2月8日 開催地：Hong Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Piv...
https://www.senju.co.jp/rd/society/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
te that the information may differ from the up-to-date information depending on when it is updated. Agree Disagree
https://www.senju.co.jp/english/rd/trial.html